MAS1L and COVID-19: Also, Malek Mahdavi has proposed the use of vitamin D in patients with COVID-19 by acting as a negative-endocrine RAS modulator and inhibits renin expression and induce ACE2/Ang-(1-7)/MasR axis activity [86].